tiprankstipranks
Trending News
More News >
Iovance Biotherapeutics (IOVA)
:IOVA
US Market

Iovance Biotherapeutics (IOVA) Cash flow

Compare
3,892 Followers

Iovance Biotherapeutics Cash Flow

IOVA's free cash flow for Q3 2025 was $-89.55M. For the 2025 fiscal year, IOVA's free cash flow was decreased by $20.06M and operating cash flow was $-78.70M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -352.98M$ -361.82M$ -292.76M$ -227.94M$ -205.13M
Investing Cash Flow
$ -96.41M$ -155.24M$ 256.45M$ 132.00K$ -317.85M
Financing Cash Flow
$ 390.66M$ 462.96M$ 190.15M$ 239.27M$ 576.42M
End Cash Position
$ 122.05M$ 181.32M$ 238.16M$ 84.31M$ 72.85M
Free Cash Flow
$ -364.05M$ -384.11M$ -313.18M$ -265.51M$ -251.93M
Currency in USD

Iovance Biotherapeutics Cash Flow